“Patient response to revumenib has been good in other clinical trials,” explains Cuglievan. “But it’s also been short-lived when used...

Pediatric acute myeloid leukemia (AML) accounts for 20% of all pediatric leukemia cases and is associated with poor outcomes, especially...

A team of researchers has demonstrated that some childhood leukemias originate during embryonic development, although they do not...

New therapies have dramatically improved survival rates among children with pediatric acute myeloid leukemia (pAML)—a cancer that starts...

Today, St. Jude Children’s Research Hospital scientists published their work on SJ3149, a compound with broad activity against many...

Scientists at St. Jude Children’s Research Hospital refined and enhanced the classification system for a type of pediatric leukemia using...

A team led by Jan-Henning Klusmann from the Department of Pediatrics and Dirk Heckl from the Institute for Experimental Pediatric...

Use of homoharringtonine (HHT) may result in improved responses among patients with pediatric acute myeloid leukemia (AML) compared with...

Pioneering research in Manchester has shown dramatic results for treating children with high-risk leukaemia (a type of blood cancer), who...

In some children, pediatric acute myeloid leukemia can become resistant to treatment; UC San Diego researchers think they now know why....